AcuCort Holds Extraordinary General Meeting

• AcuCort shareholders approved a rights issue targeting SEK 70.3 million at an extraordinary meeting on November 5, 2026.
• The issue comprises up to 78,148,177 units at SEK 0.90 each, comprising three new shares and two TO 3 warrants per unit.
• Full warrant exercise could raise another SEK 93.8 million at the maximum exercise price of SEK 0.60 per share.
• Shareholders authorized a SEK 37.51 million share capital reduction without canceling shares, allocating the reduction to unrestricted equity.
• Adopted articles amendments set capital limits at SEK 90.2 million–SEK 360.8 million, with share-count limits of 410,000,000–1,640,000,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202611051100BITN____UKPR__SV_20261105-BIT-5172-0) on November 05, 2026, and is solely responsible for the information contained therein.